Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, has been drawing attention from investors with its promising pipeline of oral small molecule products targeting a range of complex diseases. As..
Rapport Therapeutics, Inc. (NASDAQ: RAPP) is catching the eye of investors with its impressive potential upside of 103.92%. Situated in the healthcare sector and specializing in biotechnology, this Boston-based clinical-stage..
MBX Biosciences, Inc. (NASDAQ: MBX), a promising clinical-stage biopharmaceutical company, is capturing attention with its innovative approach to tackling endocrine and metabolic disorders. With a current market cap of $1.11..
Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, offers investors an intriguing prospect in the realm of specialty and generic drug manufacturing. With its headquarters in Rehovot,..
Celcuity Inc. (NASDAQ: CELC) has been turning heads in the biotechnology sector, with its innovative approach to oncology therapeutics and a significant potential upside of 11.19%. As a clinical-stage biotech..
For investors eyeing the biotechnology sector, PureTech Health plc (PRTC) presents an intriguing opportunity. With a market capitalization of $416.66 million, this Boston-based company is making waves in the healthcare..
Claritev Corporation (NASDAQ: CTEV) is carving a niche in the healthcare sector with its innovative solutions in health information services. Headquartered in New York, this company has been a stalwart..
Abivax SA (ABVX), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising potential for growth, particularly in the treatment of chronic inflammatory diseases. Headquartered..
Inventiva S.A. – American Depositary Shares (IVA) is making waves in the biotechnology sector with its promising drug pipeline and a staggering potential upside of 279.78%. The French biopharmaceutical company,..
In the rapidly evolving biotechnology industry, Fortrea Holdings Inc. (NASDAQ: FTRE) stands out as a key player, offering a range of critical services that propel biopharmaceutical and medical device innovations..
Standard BioTools Inc. (NASDAQ: LAB) presents a compelling yet complex proposition for investors eyeing the healthcare sector, specifically in the medical devices industry. With a market capitalization of $427.83 million,..
